We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$246M
AUM Growth
-$24.9M
(-9.2%)
Cap. Flow
-$29.3M
Cap. Flow
% of AUM
-11.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
16
New
3
Increased
2
Reduced
4
Closed
6
Top Buys
| 1 |
McKesson
MCK
|
+$18.8M |
| 2 |
Danaher
DHR
|
+$16.6M |
| 3 |
DaVita
DVA
|
+$10.7M |
| 4 |
Molina Healthcare
MOH
|
+$9.15M |
| 5 |
Centene
CNC
|
+$5.47M |
Top Sells
| 1 |
Labcorp
LH
|
+$21.5M |
| 2 |
Universal Health Services
UHS
|
+$19.4M |
| 3 |
Elevance Health
ELV
|
+$15.5M |
| 4 |
Medpace
MEDP
|
+$7.48M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$5.98M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Zimmer Biomet
ZBH
$17.6B
| $40.9M | 16.59% |
357,677
-33,493
| -9% | -$3.92M |
|
|
2
Centene
CNC
$32.8B
| $34M | 13.81% |
648,822
+101,247
| +18% | +$5.47M |
|
|
3
Molina Healthcare
MOH
$11.7B
| $33.7M | 13.69% |
235,686
+66,819
| +40% | +$9.15M |
|
|
4
Labcorp
LH
$23.2B
| $30.8M | 12.52% |
207,670
-153,787
| -43% | -$21.5M |
|
|
5
Elevance Health
ELV
$80.9B
| $29.6M | 12.01% |
104,849
-56,663
| -35% | -$15.5M |
|
|
6
McKesson
MCK
$98.5B
| $20.2M | 8.21% |
+150,585
| New | +$18.8M |
|
|
7
Danaher
DHR
$144B
| $17.8M | 7.22% |
+140,483
| New | +$16.6M |
|
8
HCA Healthcare
HCA
$82.3B
| $16M | 6.49% |
118,357
-40,856
| -26% | -$5.17M |
|
|
PDCO
9
DELISTED
Patterson Companies, Inc.
PDCO
| $11.7M | 4.74% |
510,054
| – | – |
|
|
10
DaVita
DVA
$15.2B
| $11.6M | 4.71% |
+206,338
| New | +$10.7M |
|
|
FOLD
11
DELISTED
Amicus Therapeutics
FOLD
| – | – |
-355,785
| Closed | -$4.84M |
|
12
Heron Therapeutics
HRTX
$89.1M
| – | – |
-166,024
| Closed | -$4.06M |
|
|
13
Medpace
MEDP
$15.4B
| – | – |
-126,887
| Closed | -$7.48M |
|
14
Travere Therapeutics
TVTX
$5.27B
| – | – |
-100,985
| Closed | -$2.29M |
|
|
15
Universal Health Services
UHS
$9.15B
| – | – |
-144,968
| Closed | -$19.4M |
|
|
ZGNX
16
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-108,734
| Closed | -$5.98M |
|
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Tavio Capital held 16 positions worth $246M, down 9.2% from $271M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tavio Capital withdrew a net $29.3M in Q2 2019, closing 6 positions and reducing 4 holdings. Its most notable exit was Universal Health Services, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Tavio Capital opened a new position in McKesson worth $20.2M.
- Tavio Capital's largest Q2 2019 buy was McKesson: 150,585 shares worth $20.2M.
- Tavio Capital added most to Molina Healthcare in Q2 2019, an estimated $9.15M increase.
- Tavio Capital's biggest Q2 2019 reduction was Labcorp, cutting an estimated $21.5M.
- Tavio Capital fully exited Universal Health Services in Q2 2019, selling an estimated $19.4M.
- Tavio Capital's ten largest holdings make up 100% of its $246M portfolio in Q2 2019.
- Tavio Capital opened 3 new positions and closed 6 in Q2 2019.
- Tavio Capital's portfolio value fell 9.2% quarter-over-quarter to $246M.
Based on Tavio Capital's 13F filing for Q2 2019, filed 13 Aug 2019.